WHO ICTRP trial
Evaluation of the Efficacy and Safety of Catheter-directed Thrombectomy and…
ChiCTR2500095253 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500095253 |
|---|---|
| Public title | Evaluation of the Efficacy and Safety of Catheter-directed Thrombectomy and Anticoagulation Therapy in Patients with Intermediate to High-Risk Pulmonary Embolism: A Prospective Multicenter Randomized Controlled Study--the CAPE trial. |
| Scientific title | Evaluation of the Efficacy and Safety of Catheter-directed Thrombectomy and Anticoagulation Therapy in Patients with Intermediate to High-Risk Pulmonary Embolism: A Prospective Multicenter Randomized Controlled Study--the CAPE trial. |
| Primary sponsor | Beijing Chao-Yang Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Pulmonary embolism |
| Interventions | Control group:Anticoagulant therapy, heparinoids given immediately after diagnosis is confirmed, unfractionated heparin pumped continuously, and APTT monitored to maintain for 50 to 70 seconds; or low molecular weight heparin according to… |
| Registration date | Jan 3, 2025 |
| Target size | Control group:78;Intervention group:78 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: